|Audentes Therapeutics Announces Appointment of John T. Gray, Ph.D. to Senior Vice President and Chief Scientific Officer|
"We are very pleased to announce John's well-earned appointment to the role of Chief Scientific Officer," stated
Dr. Gray joined Audentes with over 20 years of experience designing genetic therapies and vaccines, and developing manufacturing processes for those products. Immediately prior to Audentes, Dr. Gray served as the Director of Vector Production and Development at
For more information regarding Audentes, please visit www.audentestx.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/audentes-therapeutics-announces-appointment-of-john-t-gray-phd-to-senior-vice-president-and-chief-scientific-officer-300452772.html
Investors + Media